Bonesupport Holding AB (publ)
FSX: 2B4.F0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Frankfurt Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Torbjorn Skold
- Employees
- 140
- Headquarters
- Lund, Sweden
- IPO year
- 2017
- Market cap
- €1.4B
- Website
- https://www.bonesupport.com
Loading 2B4…
Loading profile data…Frequently asked questions about 2B4
What does Bonesupport Holding AB (publ) (2B4.F) do?
Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bioceramic bone graft substitutes for the treatment of bone voids in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable, moldable, and drillable synthetic bone void filler that includes hydroxyap...
Where does 2B4.F trade?
Bonesupport Holding AB (publ) (2B4.F) trades on the Frankfurt Stock Exchange.
What sector is 2B4.F in?
Bonesupport Holding AB (publ) (2B4.F) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Bonesupport Holding AB (publ)?
Torbjorn Skold is the chief executive officer of Bonesupport Holding AB (publ) (2B4.F).
Where is Bonesupport Holding AB (publ) headquartered?
Bonesupport Holding AB (publ) is headquartered in Sweden.
Does 2B4.F pay a dividend?
Bonesupport Holding AB (publ) (2B4.F) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 2B4.F go public?
Bonesupport Holding AB (publ) (2B4.F) completed its initial public offering in 2017.